Authors


Bob Zutaut, RPh

Latest:

Offering Specialty Infusions May Be Worth the Work for Oncology Practices

Expanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.


Mindy Smith, BSPharm, RPh, MHA, CMWA

Latest:

Driving Patient Safety With New Pharmacy HIT Standards

New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.


Carissa Treptow, PharmD, BCOP

Latest:

Multiple Myeloma Therapy Often Causes Cardiovascular Complications

Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.


Chloe Siu, PharmD, BCPS, BCOP

Latest:

Pirtobrutinib and BTK Inhibitors in the CLL Treatment Landscape

This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.


Vicki Keedy, MD

Latest:

Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.


Rachel Marini, PharmD

Latest:

Recognize the Value of Health Care Volunteers

The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.


Advit Shah, BSc, BSc Pharmacy, RPh

Latest:

How to Create an Inclusive Culture for LGBTQ+ Patients at the Pharmacy: A Practical Approach

Facilitating environmental cues that members of the LGBTQ+ community look for to signify that they are in a safe space is an especially important element for the LGBTQ+ community.


Kasey Jackson, PharmD, BCOP

Latest:

The Expanding Role of CDK 4/6 Inhibitors in Breast Cancer Treatment

Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.


Cameron Abbey-Mott, PharmD

Latest:

Clinical Overview: Dapagliflozin for Patients with Heart Failure, Reduced Ejection Fraction and Preserved Ejection Fraction

Management of heart failure focuses on avoiding reversible precipitants and optimizing guideline-directed therapy to lower mortality and hospitalizations.


Carl V. Crawford, MD

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Nishant Thakar, PharmD; Ibraheem Rajab, Bchem; and Sinni Moozhayil, BPharm, MS

Latest:

Extemporaneous Compounding of Amoxicillin Suspensions During National Shortage

As of November 2022, amoxicillin suspension has been on a national shortage list, therefore the FDA has permitted temporary compounding of amoxicillin suspensions.


Nithya Srinivasan, Director of Marketing, Rheumatology, Janssen Immunology

Latest:

Holistic Psoriatic Arthritis Care: Why Well-Being Should Be Incorporated Into the Treatment Paradigm

People living with psoriatic arthritis deserve to be informed about ways to approach disease management holistically and with a personalized approach.


Doug Field

Latest:

Pharmacies Poised to Capture At-Home Diagnostics Category

By leveraging do-it-yourself testing momentum, community-based and retail pharmacies can solidify their position as health care hubs with a category management approach that enhances the consumer experience and boosts store relevance and revenue.


Abigail Johnson

Latest:

Study Highlights Pharmacy Student Perspective on Mental Health, Future Practice

Pharmacy programs are implementing new practices into their curriculum and research is being focused on mental health care.


Gabriela G. Abrego, MPH

Latest:

Applying an Error Prevention Process to a COVID-19 Vaccination Clinic

An overview for community pharmacies of a process to minimize vaccine errors using a COVID-19 vaccine point of distribution as an example.


Pranav Garimella, MBBS, MPH

Latest:

Insight: Pharmacists Play Key Role in Educating Patients With CKD on Semaglutide Use, Management

According to Pranav Garimella, pharmacists are essential in counseling patients with CKD on the appropriate use of semaglutide.


Natalija M. Farrell, PharmaD, BCPS, DABAT, FAACT

Latest:

Vaccinations in the Emergency Department: Current and Emerging Practices to Boost Public Health

Piloting new emergency department-based vaccination campaigns and fine-tuning existing programs may reduce morbidity and mortality associated with vaccine-preventable diseases.



Jacob Curcio, PharmD

Latest:

A Primer for Medical Specialty Drug Utilization Management Strategies

Case management programs or pharmacist-delivered high-touch care are critical components in medical specialty drug management.


Rachel A. Galbo, PharmD, BCACP, CDCES

Latest:

A Pharmacist’s Guide to Continuous Glucose Monitoring

This guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.


Amir Ali, PharmD, BCOP

Latest:

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.


Sarah O'Neill, PharmD

Latest:

Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple Myeloma

Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.


Dawn DiPasquale, CPhT, CTDP

Latest:

Education, Training, Collaboration Key Areas of Focus at ASHP

Shields Health Solutions poster presentations highlight a comprehensive approach to specialty patient care and successful results from an expanded offering of instructional programs.


Sarah E Leist, PharmD Candidate

Latest:

Purchasing Discounted Medications Online Can Pose Dangers for Patients

With the increase in counterfeit GLP-1 and GLP/GIP medications available online, education may be needed for patients around the dangers of unregulated medications.


Ariana Paras, PharmD Candidate

Latest:

Bridging the Gap: How Pharmacists Can Expand and Transform Mental Health Services

This expansion of their role goes beyond traditional dispensing duties, positioning pharmacists as an essential bridge between patients and the broader health care system.



Sarah A. Alwardt, PhD

Latest:

Lung Cancer Study Brings Pharmacists to the Forefront of Patient Care

Pharmacists have always been a vital member of the cancer care team, but the emergence of many new oral therapies is making their role in patient care a more prominent one.


Ryan Himes, PharmD

Latest:

GLP-1s Are At the Forefront, but Other Obesity Treatments Exist

In addition to GLP-1s, dual GLP-1 and GIP agonists, intestinal lipase inhibitors, sympathomimetics, and other agents can help patients lose weight.


Lauren Caldas, PharmD, BCACP

Latest:

Lessons Learned by a Student Pharmacist on Instagram

There are key benefits and risks for student pharmacists to consider when approaching an Instagram account for professional pharmacy purposes.


Ryan Haumschild, PharmD, MS, MBA, CPEL

Latest:

Additional Considerations With PBC Therapies

Panelists discuss how recent FDA regulatory actions regarding obeticholic acid have raised concerns about its long-term safety profile and accessibility, leading health care teams to develop strategies for supporting patients through treatment transitions while navigating insurance coverage and access challenges for newer primary biliary cholangitis (PBC) therapies.